Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
32,832,112
-
Shares change
-
-1,098,879
-
Total reported value, excl. options
-
$307,624,848
-
Value change
-
-$28,979,577
-
Put/Call ratio
-
26%
-
Number of buys
-
70
-
Number of sells
-
44
-
Price
-
$9.37
Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q4 2022
As of 31 Dec 2022 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) had 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,832,112 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, Bain Capital Life Sciences Investors, LLC, MILLENNIUM MANAGEMENT LLC, Madison Avenue Partners, LP, and EcoR1 Capital, LLC.
This table shows 132 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.